Clinical observation of the reduced glutathione in the treatment of diabetic chronic kidney disease.

Background: Diabetic chronic kidney disease (CKD) has become the main cause of death in diabetic patients, but its pathogenesis has not yet been clear.

Objective: To investigate the effects of reduced glutathione (GSH) on oxidative stress (OS), angiogenesis factors and lymphocyte subsets in diabetic CKD patients.

Methods: A total of 130 subjects were retrospectively studied.